Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSarepta Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Sarepta Therapeutics, Inc.

$20.81Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $401.25M. Net result −$4.89M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $401.25M. Running result $401.25M. Revenue: $401.25M.
  • Operating costs: −$387.96M. Running result $13.29M.
  • Operating income: $13.29M. Running result $13.29M.
  • Other expense: −$15.04M. Running result −$1.75M.
  • Pre-tax loss: −$1.75M. Running result −$1.75M.
  • Income tax expense: −$3.14M. Running result −$4.89M.
  • Net loss: −$4.89M. Running result −$4.89M.